Sulf-15

   
Google
 
Web NewDrugInformation.com

Sulf-15


Drug - Sulf-15
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Sulfacetamide Sodium
Multiple ingredients are in alphabetical order.

Strength - 15%
The potency of the active ingredient(s), Sulfacetamide Sodium. May repeat for multiple part products.

Applicant - NOVARTIS
The firm name holding legal responsibility for Sulf-15. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 089047
The FDA assigned number to Sulf-15. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Sulf-15. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 31, 1995
The date Sulf-15 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Sulf-15. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Sulf-15 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novartis Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Sulf-15.

Sulf-15